Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GAO Finds "Personalized" Supplement Offers In DTC Genetic Testing Report

This article was originally published in The Tan Sheet

Executive Summary

An investigation into direct-to-consumer genetic testing products finds some firms marketing allegedly customized dietary supplement regimens to consumers based on their test results

You may also be interested in...



FDA To Regulate Direct-To-Consumer Genetic Tests

FDA sent letters to five genetic testing firms requesting pre-market submissions for the companies' already-marketed services, citing the need to prove that direct-to-consumer genetic assays are analytically and clinically accurate

Senate Supplement Hearing Spotlights Self-Regulation, FDA Enforcement

A Government Accountability Office investigation intended to shed light on whether senior citizens are at risk when buying herbal supplements has refueled debate on the effectiveness of both FDA enforcement and industry self-regulation

FDA Cites Long-Term Precedent In Blocking Retail Genetic Screening Plans

A particularly public pre-emptive stance by FDA's in vitro diagnostics oversight office halts Pathway Genomics' plans to start selling genetic screening test sample collection kits out of Walgreens stores, but the office's director stresses the move does not signal any changes to its enforcement policy for laboratory-developed tests

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104335

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel